NASDAQ:TTRX | Free Cash Flow | Turn Therapeutics Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2024-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$1.63M
2025-12-31-$1.18M
2025-03-31-$298,058.00
2024-12-31-$430,545.00

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$2.56M
2024-12-31-$1.36M

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.